BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23633307)

  • 1. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Main C; Knight B; Moxham T; Gabriel Sanchez R; Sanchez Gomez LM; Roqué i Figuls M; Bonfill Cosp X
    Cochrane Database Syst Rev; 2013 Apr; (4):CD002229. PubMed ID: 23633307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women.
    Gabriel SR; Carmona L; Roque M; Sánchez GL; Bonfill X
    Cochrane Database Syst Rev; 2005 Apr; (2):CD002229. PubMed ID: 15846631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar C; Marjoribanks J; Lethaby A; Suckling JA; Lamberts Q
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004143. PubMed ID: 19370593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis.
    Li C; Lv Z; Shi Z; Zhu Y; Wu Y; Li L; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2014 Aug; (8):CD009197. PubMed ID: 25123257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.
    Javed AA; Mayhew AJ; Shea AK; Raina P
    JAMA Netw Open; 2019 Aug; 2(8):e1910154. PubMed ID: 31461147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.